Executive Summary

Oct 2019
PROSPECTS
Topical antifungals accounts for the largest share of value sales as rashes and scabies are particularly common in Indonesia with its tropical climate

Topical antifungals posted stable, small growth but continued to account for the largest value share within dermatologicals in 2019. Indonesia’s tropical climate with its high humidity makes rashes and scabies quite common in the country, particularly for people that live in unsanitary neighbourhoods.

Positive birth rate, heat and humidity and, some say, high exposure to mobile phones increase the incidence of heat rashes

Nappy (diaper) rash treatments saw the highest value growth in 2019, and the positive birth rate in Indonesia is expected to keep sales growing. Recently, the higher frequency of baby skin rashes has not only been attributed to the heat and humidity but also to the increasing pollution levels in the country.

Sales of medicated shampoo set to continue slowing down as women increasingly consult with dermatological clinics and buy such products there

Increasing concern about the condition of their skin and hair as well as higher spending power has led more women to consult a dermatologist for advice or treatment, especially for facial skin. This trend could negatively affect the sales of OTC medicated shampoo, since dermatological clinics usually have their own products to sell to their clients.

COMPETITIVE LANDSCAPE
Johnson & Johnson brands maintain the lead in topical antifungals and nappy (diaper) rash treatments

Johnson & Johnson maintained its lead in dermatologicals in 2019 on the strength of Daktarin and Daktarin Diaper, the leading brands among topical antifungals and nappy (diaper) rash treatments. Topical antifungals accounted for the highest share of dermatologicals value sales and the only dermatological category that saw higher value growth over the year was nappy (diaper) rash treatments.

Betadine remains the dominant topical antiseptic product but entry of Hansaplast in the category is expected to increase the competition

Mahakam Beta Farma’s Betadine also continued dominate topical germicidals/antiseptics in 2019, as it has yet little competition in the country. Betadine is so well known in Indonesia that the brand has become a term for iodine.

Store-based retailers remain the main distribution channels for dermatologicals

Store-based retailers such as chemists/pharmacies and drugstores/parapharmacies continue to comprise the major distribution channels for dermatological products, since people tend to seek advice and confirmation from specialists such as pharmacists in store-based outlets. Dermatological products are almost always available in pharmacies and drugstores, but antiseptics and antipruritics also can be obtained in more easily accessible channels such as convenience stores.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Indonesia

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Indonesia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Indonesia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Indonesia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Indonesia?
  • What are the major brands in Indonesia?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Indonesia - Category analysis

HEADLINES

PROSPECTS

Topical antifungals accounts for the largest share of value sales as rashes and scabies are particularly common in Indonesia with its tropical climate
Positive birth rate, heat and humidity and, some say, high exposure to mobile phones increase the incidence of heat rashes
Sales of medicated shampoo set to continue slowing down as women increasingly consult with dermatological clinics and buy such products there

COMPETITIVE LANDSCAPE

Johnson & Johnson brands maintain the lead in topical antifungals and nappy (diaper) rash treatments
Betadine remains the dominant topical antiseptic product but entry of Hansaplast in the category is expected to increase the competition
Store-based retailers remain the main distribution channels for dermatologicals

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Indonesia - Industry Overview

EXECUTIVE SUMMARY

Unstable weather and environmental conditions drive increased demand for consumer healthcare
Rapidly developing healthcare start-ups offer Indonesia’s rural population greater access to services
Leading players in consumer health are both international and domestic, with local players maintaining their greatest strength in herbal/traditional products
Internet retailing growth is further advanced by widening online offer and fast product delivery
Value growth of consumer healthcare is ensured as demand continues to increase

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources